Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-188P is a pseudogene of the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential and highly conserved non-coding RNA that forms the catalytic core of the spliceosome, the molecular machinery responsible for removing introns from pre-mRNA in eukaryotic cells[1][3]. However, as indicated by its annotation as a pseudogene, RNU6-188P does **not produce a functional RNA product** and is not actively involved in splicing or other cellular processes. Vertebrate genomes contain many copies and pseudogenes related to functional U6 snRNA genes[1]. The existence of these pseudogenes is believed to result from evolutionary duplication events, but they are not typically transcribed or translated into active molecules, and thus **do not serve as therapeutic targets or biomarkers**. The true biological and clinical research focus is on the functional U6 snRNA, not its pseudogenic copies. Notes for interpretation: - RNU6-188P is **not a protein, receptor, enzyme, or actively expressed RNA**; it is classified as a **pseudogene**. - It is **not a therapeutic target** and has no documented roles in disease, drug interaction, or molecular mechanism. - This entry is **potentially misleading** for therapeutic or biological targeting, as the focus in scientific literature is on the functional U6 snRNA rather than on specific pseudogenes such as RNU6-188P[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 188, pseudogene (RNU6-188P).